Smartphone app to help people quit smoking
Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study
This study is testing a smartphone app that helps people in Texas quit smoking by giving them personalized plans and support from nicotine patches.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05763771 on ClinicalTrials.gov |
What this trial studies
This study aims to develop and evaluate a smartphone app designed to assist individuals in reducing or quitting smoking. Participants will use the app, which generates personalized smoking schedules and records smoking behavior, alongside nicotine patches for support. The study will assess the app's usability and its preliminary effects on smoking cessation over a four-week period with participants recruited from Texas. A total of 60 participants will be randomly assigned to either the app intervention group or a control group receiving standard care.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who smoke an average of 10 or more cigarettes per day and are seeking help to quit.
Not a fit: Patients who do not smoke or those who are not willing to reduce their smoking may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could provide a novel and effective tool for individuals seeking to quit smoking.
How similar studies have performed: Previous studies have shown promise in using mobile apps for smoking cessation, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Age: 18 years old or older * Smoking: an average of 10 or more cigarettes, little cigars, or cigarillos combined per day within the past 30 days preceding the phone screen * Expired carbon monoxide (CO): \> 6 ppm * Can install and run the study app on their Android smartphone, or agree to use the study smartphone loaned from the research team * Agree to return the study smartphone if the participant loans one from the research team * Willing to reduce smoking (Aim 1) * Seeking smoking cessation treatment (Aim 2) * Fluency in spoken and written English * Agree to be treated via telehealth (live audio-video conference and phone) and to be contacted via text and/or email * Provide informed consent and agree to all assessments and study procedures * Willing to refrain from the use of other nicotine/tobacco products for the duration of the study * Willing to refrain from the use of marijuana, prescription medications not prescribed to the participant, and illegal drugs Exclusion Criteria: * Taking psychotropic, anticonvulsive, or narcotic medication * Meet criteria for a current major depressive episode or suicidality according to the PHQ (indicated by a score of 10 or higher). * Involved in current and imminent (within the next 45 days) smoking cessation activity * Women who are pregnant or breastfeeding * Shares the same address as a currently enrolled participant * Unwilling to use or allergic to nicotine patches (Aim 2) * Considered by the investigator to be an unsuitable or unstable candidate, such as those who appear to have cognitive impairment, and those who reside in a shelter, group/recovery facility, or treatment facility * Any plans to move out of the state in the next 6 months * Using marijuana, prescription medications not prescribed to the participant, and illegal drugs on a daily basis * Have experienced abnormal heart rhythms or cardiovascular disease, such as stroke, chest pain, and heart attack, in the last month (Aim 2)
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Yong Cui, PHD — M.D. Anderson Cancer Center
- Study coordinator: Yong Cui, PHD
- Email: ycui1@mdanderson.org
- Phone: (713) 792-7837
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.